EO Kutumova, IR Akberdin, IN Kiselev… - International Journal of …, 2022 - mdpi.com
Cancer treatment and pharmaceutical development require targeted treatment and less toxic therapeutic intervention to achieve real progress against this disease. In this scenario …
Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer with a∼ 50% response rate to immune checkpoint blockade (ICB) therapy. To identify predictive …
T Vu, J Wrobel, BG Bitler, EL Schenk… - PLoS computational …, 2022 - journals.plos.org
The tumor microenvironment (TME), which characterizes the tumor and its surroundings, plays a critical role in understanding cancer development and progression. Recent …
C Wilson, AC Soupir, R Thapa, J Creed… - PLoS computational …, 2022 - journals.plos.org
New technologies, such as multiplex immunofluorescence microscopy (mIF), are being developed and used for the assessment and visualization of the tumor immune …
AC Soupir, MT Hayes, TC Peak, O Ospina… - Genome biology, 2024 - Springer
Immunotherapy has improved survival for patients with advanced clear cell renal cell carcinoma (ccRCC), but resistance to therapy develops in most patients. We use cellular …
Technologies that produce spatial single-cell (SC) data have revolutionized the study of tissue microstructures and promise to advance personalized treatment of cancer by …
Advances in multiplexed single-cell immunofluorescence (mIF) and multiplex immunohistochemistry (mIHC) imaging technologies have enabled the analysis of cell-to …
Multiplexed spatial proteomics reveals the spatial organization of cells in tumors, which is associated with important clinical outcomes such as survival and treatment response. This …
Recent advances in types and extant of medical imaging technologies has led to proliferation of multimodal quantitative imaging data in cancer. Quantitative medical imaging …